Active ingridient is Troxerutin - a derivative of the extract from sophora japonica (japanese pagoda tree)
Troxevasin has been widely used in Europe since the mid-1960s to manage a range of venous disorders.
Varicose and Venous insufficiency.
In varicose veins blood pools within the vein and apply pressure against walls of the veins and capillaries (see table below). Venous insufficiency is a closely related condition to varicose veins affecting larger veinsdeep within the leg.
Both conditions are often characterised by pain, aching, swelling, and feelings of heaviness and fatigue.
Varicose veins may also present a cosmetic problem with bulging, often ropy, blue or purple lines visible on the skin of the lower legs. Numerous double- blind placebo-controlled studies, involving more than 2,000 patients have
examined the effectiveness of Troxerutin for the management of varicose veins and venous insufficiency.
All but one found that troxerutin significantly more effective than placebo, giving substantial relief from swelling, aching, leg pains, and other uncomfortable symptoms, while causing no significantside effects (1-70).